PTC596 has been studied in advanced solid tumors in clinical trials. However, the effects of PTC596 alone or in combination with programmed cell death protein-1 (PD1) blockade in hepatocellular carcinoma (HCC) remain unclear. Subcutaneous tumor models in both ... ...

请注册登录后继续浏览